{"id":5467,"date":"2023-11-03T15:34:50","date_gmt":"2023-11-03T20:34:50","guid":{"rendered":"https:\/\/nanostherapeutics.com\/?p=5467"},"modified":"2025-06-27T11:28:56","modified_gmt":"2025-06-27T16:28:56","slug":"nanoscope-therapeutics-awarded-best-of-show-for-retina-at-eyeceleratoraao-2023","status":"publish","type":"post","link":"https:\/\/nanostherapeutics.com\/ja\/2023\/11\/03\/nanoscope-therapeutics-awarded-best-of-show-for-retina-at-eyeceleratoraao-2023\/","title":{"rendered":"Nanoscope Therapeutics \u304c Eyecelerator@AAO 2023 \u3067 Retina \u306e\u300c\u30d9\u30b9\u30c8 \u30aa\u30d6 \u30b7\u30e7\u30fc\u300d\u3092\u53d7\u8cde"},"content":{"rendered":"
\n

<\/h1>\n<\/div>\n
\n
\n
\n
\n

\u30c6\u30ad\u30b5\u30b9\u5dde\u30c0\u30e9\u30b9 (2020 \u5e74 11 \u6708 3 \u65e5) \u2014 \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u682a\u5f0f\u4f1a\u793e<\/a>\u907a\u4f1d\u6027\u7db2\u819c\u75be\u60a3\u304a\u3088\u3073\u52a0\u9f62\u9ec4\u6591\u5909\u6027\u75c7\uff08AMD\uff09\u306e\u907a\u4f1d\u5b50\u6cbb\u7642\u3092\u958b\u767a\u3059\u308b\u81e8\u5e8a\u6bb5\u968e\u306e\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u304c\u3001Eyecelerator@AAO2023\u3067\u300c\u7db2\u819c\u306e\u30d9\u30b9\u30c8\u30fb\u30aa\u30d6\u30fb\u30b7\u30e7\u30fc\u300d\u3092\u53d7\u8cde\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u8cde\u306f\u3001\u30a4\u30d9\u30f3\u30c8\u306e Retina \u30b7\u30e7\u30fc\u30b1\u30fc\u30b9\u3067\u306e\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u306b\u5bfe\u3057\u3066 Nanoscope \u306e\u6700\u9ad8\u533b\u7642\u8cac\u4efb\u8005\u3001Samuel Barone \u533b\u5e2b\u306b\u6388\u4e0e\u3055\u308c\u307e\u3057\u305f\u3002 Barone\u535a\u58eb\u306f\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u306e\u4e2d\u3067\u3001\u540c\u793e\u306eMulti-Characteristic Opsin\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3068\u3001\u9032\u884c\u6027\u7db2\u819c\u5909\u6027\u75be\u60a3\u60a3\u8005\u306e\u6700\u8fd1\u306e\u81e8\u5e8a\u30c7\u30fc\u30bf\u306b\u57fa\u3065\u3044\u305f\u8996\u529b\u56de\u5fa9\u306e\u53ef\u80fd\u6027\u3092\u7d39\u4ecb\u3057\u305f\u3002<\/p>\n

\"\"
\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u306e\u6700\u9ad8\u533b\u7642\u8cac\u4efb\u8005\u3067\u3042\u308b\u30b5\u30e0\u30fb\u30d0\u30ed\u30fc\u30f3\u533b\u5e2b\u306f\u30012023\u5e7411\u67082\u65e5\u306b\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u3067\u958b\u50ac\u3055\u308c\u305fEyecelerator@AAO2023\u306b\u304a\u3044\u3066\u3001\u300c\u30d9\u30b9\u30c8\u30fb\u30aa\u30d6\u30fb\u30b7\u30e7\u30fc \u2013 \u7db2\u819c\u90e8\u9580\u300d\u8cde\u3092\u53d7\u8cde\u3057\u307e\u3057\u305f\u3002<\/figcaption><\/figure>\n

\u30d9\u30b9\u30c8 \u30aa\u30d6 \u30b7\u30e7\u30fc\u8cde\u306e\u53d7\u8cde\u8005\u306f\u3001\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\u51fa\u5e2d\u8005\u306e\u6295\u7968\u306b\u3088\u3063\u3066\u9078\u3070\u308c\u307e\u3059\u3002 CEO\u306eSulagna Bhattacharya\u6c0f\u306f\u3001\u300c\u3053\u306e\u8a55\u4fa1\u306b\u79c1\u305f\u3061\u306f\u8208\u596e\u3057\u3066\u304a\u308a\u3001\u5149\u6804\u306b\u601d\u3063\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u306f\u79c1\u305f\u3061\u81ea\u8eab\u306e\u7db2\u819c\u30b3\u30df\u30e5\u30cb\u30c6\u30a3\u304b\u3089\u306e\u3082\u306e\u3067\u3042\u308b\u305f\u3081\u3001\u975e\u5e38\u306b\u7279\u5225\u3067\u3059\u3002\u300d\u3068\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u52b1\u307e\u3057\u3066\u304f\u3060\u3055\u3063\u305f\u7686\u69d8\u306b\u611f\u8b1d\u3044\u305f\u3057\u307e\u3059\u3002\u3053\u308c\u306f\u79c1\u305f\u3061\u306e\u30c1\u30fc\u30e0\u5168\u4f53\u306b\u3068\u3063\u3066\u975e\u5e38\u306b\u5927\u304d\u306a\u610f\u5473\u304c\u3042\u308a\u307e\u3059\u3002\u300d<\/p>\n

\u201c\u300c\u79c1\u306e\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u3067\u306f\u60a3\u8005\u3055\u3093\u306e\u4f53\u9a13\u3092\u6700\u512a\u5148\u4e8b\u9805\u3068\u3057\u3066\u304a\u308a\u3001\u60a3\u8005\u3055\u3093\u306e\u751f\u6d3b\u306b\u5909\u5316\u3092\u3082\u305f\u3089\u3059\u305f\u3081\u306e\u79c1\u305f\u3061\u306e\u53d6\u308a\u7d44\u307f\u3092\u8a55\u4fa1\u3057\u3066\u3044\u305f\u3060\u3051\u305f\u3053\u3068\u306b\u611f\u8b1d\u3057\u3066\u3044\u307e\u3059\u300d\u3068\u3001\u6700\u9ad8\u533b\u7642\u8cac\u4efb\u8005\u306e\u30b5\u30df\u30e5\u30a8\u30eb\u30fb\u30d0\u30ed\u30fc\u30f3\u306f\u8ff0\u3079\u305f\u3002.<\/p>\n

\"\"
Nanoscope Therapeutics\u306e\u7d4c\u55b6\u9663\u304c\u3001Eyecelerator\u3067\u300cBest of Show\u300d\u8cde\u3092\u53d7\u8cde\u3057\u3001\u795d\u8cc0\u30e0\u30fc\u30c9\u306b\u5305\u307e\u308c\u3066\u3044\u307e\u3059\u3002\u5de6\u304b\u3089\u3001\u6226\u7565\u30fb\u4e8b\u696d\u62c5\u5f53\u526f\u793e\u9577\u306e\u30b8\u30e3\u30ec\u30c3\u30c9\u30fb\u30b9\u30c6\u30a3\u30fc\u30d6\u30f3\u30b9\u6c0f\u3001\u5171\u540c\u5275\u696d\u8005\u517c\u793e\u9577\u306e\u30b5\u30de\u30ec\u30f3\u30c9\u30e9\u30fb\u30e2\u30cf\u30f3\u30c6\u30a3\u6c0f\u3001\u6700\u9ad8\u533b\u7642\u8cac\u4efb\u8005\u306e\u30b5\u30e0\u30fb\u30d0\u30ed\u30fc\u30f3\u6c0f\u3001CEO\u306e\u30b9\u30e9\u30cb\u30e3\u30fb\u30d0\u30c3\u30bf\u30c1\u30e3\u30ea\u30e4\u6c0f\u3001CFO\u306e\u30de\u30a4\u30b1\u30eb\u30fb\u30de\u30eb\u30b1\u30b9\u6c0f\u3002.<\/figcaption><\/figure>\n

Eyecelerator@AAO2023 \u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u3067\u306e\u7c73\u56fd\u773c\u79d1\u5b66\u4f1a\u5e74\u6b21\u7dcf\u4f1a\u306b\u5148\u7acb\u3061\u30012023 \u5e74 11 \u6708 2 \u65e5\u306b\u958b\u50ac\u3055\u308c\u307e\u3057\u305f\u3002 Eyecelerator \u306f\u3001\u30a2\u30a4\u30b1\u30a2\u306b\u304a\u3051\u308b\u65b0\u305f\u306a\u30c8\u30ec\u30f3\u30c9\u3001\u9032\u6b69\u3001\u9769\u65b0\u306b\u7126\u70b9\u3092\u5f53\u3066\u3066\u3044\u307e\u3059\u3002<\/p>\n

\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u306b\u3064\u3044\u3066
\n<\/strong>Nanoscope Therapeutics \u306f\u3001\u6cbb\u7642\u6cd5\u304c\u5b58\u5728\u3057\u306a\u3044\u907a\u4f1d\u6027\u7db2\u819c\u75be\u60a3\u306b\u3088\u3063\u3066\u5931\u660e\u3057\u305f\u4f55\u767e\u4e07\u4eba\u3082\u306e\u60a3\u8005\u3092\u5bfe\u8c61\u306b\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u305b\u305a\u8996\u529b\u3092\u56de\u5fa9\u3059\u308b\u5149\u907a\u4f1d\u5b66\u7684\u6cbb\u7642\u6cd5\u3092\u958b\u767a\u3057\u3066\u3044\u307e\u3059\u3002\u540c\u793e\u306e\u4e3b\u8981\u8cc7\u7523\u3067\u3042\u308b MCO-010 \u306f\u3001\u7c73\u56fd\u3067\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u3092\u5bfe\u8c61\u3068\u3057\u305f RESTORE \u7b2c 2b \u76f8\u591a\u65bd\u8a2d\u7121\u4f5c\u70ba\u5316\u4e8c\u91cd\u30de\u30b9\u30af\u507d\u5bfe\u7167\u81e8\u5e8a\u8a66\u9a13\u306e\u30c8\u30c3\u30d7\u30e9\u30a4\u30f3\u7d50\u679c\u3092\u6700\u8fd1\u5831\u544a\u3057\u307e\u3057\u305f (NCT04945772<\/a>\uff09\u3002\u540c\u793e\u306f\u6700\u8fd1\u3001\u30b7\u30e5\u30bf\u30eb\u30ac\u30eb\u30c8\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305f MCO-010 \u7642\u6cd5\u306e\u7b2c 2 \u76f8 STARLIGHT \u8a66\u9a13\u306e\u305f\u3081\u306e\u7814\u7a76\u7d42\u4e86\u6642\u306e\u8a2a\u554f\u3082\u5b8c\u4e86\u3057\u307e\u3057\u305f (NCT05417126<\/a>\uff09\u3002 MCO-010\u306f\u3001\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u3068\u30b7\u30e5\u30bf\u30eb\u30ac\u30eb\u30c8\u306e\u4e21\u65b9\u306b\u5bfe\u3057\u3066FDA\u30d5\u30a1\u30b9\u30c8\u30c8\u30e9\u30c3\u30af\u6307\u5b9a\u304a\u3088\u3073FDA\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u3066\u3044\u307e\u3059\u3002\u524d\u81e8\u5e8a\u8cc7\u7523\u306b\u306f\u3001\u5730\u7406\u7684\u840e\u7e2e\u306b\u5bfe\u3059\u308b\u975e\u30a6\u30a4\u30eb\u30b9\u30ec\u30fc\u30b6\u30fc\u306b\u3088\u308b MCO-020 \u907a\u4f1d\u5b50\u6cbb\u7642\u304c\u542b\u307e\u308c\u307e\u3059\u3002<\/p>\n

\u00a0<\/strong><\/p>\n

\u6295\u8cc7\u5bb6\u9023\u7d61\u5148:<\/b>
\u30a2\u30eb\u30b4\u30c3\u30c8\u30d1\u30fc\u30c8\u30ca\u30fc\u30ba
212-600-1902
PR@nanostherapeutics.com<\/a><\/p>\n

\u51fa\u5178 \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9<\/p>\n<\/div>\n<\/div>\n<\/section>\n<\/article>","protected":false},"excerpt":{"rendered":"

DALLAS, TX (November 3, 2020) \u2014 Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases and age-related macular degenerations (AMD), has been awarded \u201cBest of Show for Retina\u201d at Eyecelerator@AAO2023. The award was presented to Nanoscope\u2019s Chief Medical Officer, Samuel Barone, MD, for his presentation during the event\u2019s Retina Showcase.\u00a0 In his presentation Dr. Barone showcased the company\u2019s Multi-Characteristic Opsin platform and its potential to restore vision based on recent clinical data in patients with advanced retinal degenerative diseases. Recipient of the Best of Show Award is chosen by a vote of conference attendees. \u201cWe are thrilled and honored for this recognition,\u201d said Sulagna Bhattacharya, […]<\/p>\n","protected":false},"author":6,"featured_media":5469,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[13,8],"tags":[],"class_list":["post-5467","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home-page","category-nanoscope-press-release"],"yoast_head":"\nNanoscope Therapeutics Awarded \u2018Best of Show\u2019 for Retina at Eyecelerator@AAO 2023 - Nanoscope Therapeutics<\/title>\n<meta name=\"description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanostherapeutics.com\/ja\/2023\/11\/03\/nanoscope-therapeutics-awarded-best-of-show-for-retina-at-eyeceleratoraao-2023\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanoscope Therapeutics Awarded \u2018Best of Show\u2019 for Retina at Eyecelerator@AAO 2023 - Nanoscope Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanostherapeutics.com\/ja\/2023\/11\/03\/nanoscope-therapeutics-awarded-best-of-show-for-retina-at-eyeceleratoraao-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanoscope Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-03T20:34:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-27T16:28:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2023\/11\/NSCOPE_team_eyecelerator_bestofshow.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1352\" \/>\n\t<meta property=\"og:image:height\" content=\"1077\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nanoscope Therapeutics\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2023\/09\/NSCOPE_LI_Barone_final2.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:site\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nanoscope Therapeutics\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"3\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/11\\\/03\\\/nanoscope-therapeutics-awarded-best-of-show-for-retina-at-eyeceleratoraao-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/11\\\/03\\\/nanoscope-therapeutics-awarded-best-of-show-for-retina-at-eyeceleratoraao-2023\\\/\"},\"author\":{\"name\":\"Nanoscope Therapeutics\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\"},\"headline\":\"Nanoscope Therapeutics Awarded \u2018Best of Show\u2019 for Retina at Eyecelerator@AAO 2023\",\"datePublished\":\"2023-11-03T20:34:50+00:00\",\"dateModified\":\"2025-06-27T16:28:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/11\\\/03\\\/nanoscope-therapeutics-awarded-best-of-show-for-retina-at-eyeceleratoraao-2023\\\/\"},\"wordCount\":399,\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/11\\\/03\\\/nanoscope-therapeutics-awarded-best-of-show-for-retina-at-eyeceleratoraao-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/NSCOPE_team_eyecelerator_bestofshow.jpg\",\"articleSection\":[\"Home Page\",\"Nanoscope Press Release\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/11\\\/03\\\/nanoscope-therapeutics-awarded-best-of-show-for-retina-at-eyeceleratoraao-2023\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/11\\\/03\\\/nanoscope-therapeutics-awarded-best-of-show-for-retina-at-eyeceleratoraao-2023\\\/\",\"name\":\"Nanoscope Therapeutics Awarded \u2018Best of Show\u2019 for Retina at Eyecelerator@AAO 2023 - Nanoscope Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/11\\\/03\\\/nanoscope-therapeutics-awarded-best-of-show-for-retina-at-eyeceleratoraao-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/11\\\/03\\\/nanoscope-therapeutics-awarded-best-of-show-for-retina-at-eyeceleratoraao-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/NSCOPE_team_eyecelerator_bestofshow.jpg\",\"datePublished\":\"2023-11-03T20:34:50+00:00\",\"dateModified\":\"2025-06-27T16:28:56+00:00\",\"description\":\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/11\\\/03\\\/nanoscope-therapeutics-awarded-best-of-show-for-retina-at-eyeceleratoraao-2023\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/11\\\/03\\\/nanoscope-therapeutics-awarded-best-of-show-for-retina-at-eyeceleratoraao-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/11\\\/03\\\/nanoscope-therapeutics-awarded-best-of-show-for-retina-at-eyeceleratoraao-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/NSCOPE_team_eyecelerator_bestofshow.jpg\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/NSCOPE_team_eyecelerator_bestofshow.jpg\",\"width\":1352,\"height\":1077},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/11\\\/03\\\/nanoscope-therapeutics-awarded-best-of-show-for-retina-at-eyeceleratoraao-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanoscope Therapeutics Awarded \u2018Best of Show\u2019 for Retina at Eyecelerator@AAO 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"name\":\"Nanoscope Therapeutics\",\"description\":\"Bringing Back the Light of Hope\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"alternateName\":\"Nanoscope Therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanostherapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\",\"name\":\"Nanoscope Therapeutics, Inc\",\"alternateName\":\"Nanoscope Therapeutics\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"width\":512,\"height\":435,\"caption\":\"Nanoscope Therapeutics, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/NSTherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanoscope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\",\"name\":\"Nanoscope Therapeutics\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u304cEyecelerator@AAO 2023\u3067\u7db2\u819c\u90e8\u9580\u306e\u300c\u30d9\u30b9\u30c8\u30fb\u30aa\u30d6\u30fb\u30b7\u30e7\u30fc\u300d\u3092\u53d7\u8cde - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanostherapeutics.com\/ja\/2023\/11\/03\/nanoscope-therapeutics-awarded-best-of-show-for-retina-at-eyeceleratoraao-2023\/","og_locale":"ja_JP","og_type":"article","og_title":"Nanoscope Therapeutics Awarded \u2018Best of Show\u2019 for Retina at Eyecelerator@AAO 2023 - Nanoscope Therapeutics","og_description":"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.","og_url":"https:\/\/nanostherapeutics.com\/ja\/2023\/11\/03\/nanoscope-therapeutics-awarded-best-of-show-for-retina-at-eyeceleratoraao-2023\/","og_site_name":"Nanoscope Therapeutics","article_published_time":"2023-11-03T20:34:50+00:00","article_modified_time":"2025-06-27T16:28:56+00:00","og_image":[{"width":1352,"height":1077,"url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2023\/11\/NSCOPE_team_eyecelerator_bestofshow.jpg","type":"image\/jpeg"}],"author":"Nanoscope Therapeutics","twitter_card":"summary_large_image","twitter_image":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2023\/09\/NSCOPE_LI_Barone_final2.jpg","twitter_creator":"@NSTherapeutics","twitter_site":"@NSTherapeutics","twitter_misc":{"\u57f7\u7b46\u8005":"Nanoscope Therapeutics","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"3\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanostherapeutics.com\/2023\/11\/03\/nanoscope-therapeutics-awarded-best-of-show-for-retina-at-eyeceleratoraao-2023\/#article","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/2023\/11\/03\/nanoscope-therapeutics-awarded-best-of-show-for-retina-at-eyeceleratoraao-2023\/"},"author":{"name":"Nanoscope Therapeutics","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2"},"headline":"Nanoscope Therapeutics Awarded \u2018Best of Show\u2019 for Retina at Eyecelerator@AAO 2023","datePublished":"2023-11-03T20:34:50+00:00","dateModified":"2025-06-27T16:28:56+00:00","mainEntityOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2023\/11\/03\/nanoscope-therapeutics-awarded-best-of-show-for-retina-at-eyeceleratoraao-2023\/"},"wordCount":399,"publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2023\/11\/03\/nanoscope-therapeutics-awarded-best-of-show-for-retina-at-eyeceleratoraao-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2023\/11\/NSCOPE_team_eyecelerator_bestofshow.jpg","articleSection":["Home Page","Nanoscope Press Release"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/nanostherapeutics.com\/2023\/11\/03\/nanoscope-therapeutics-awarded-best-of-show-for-retina-at-eyeceleratoraao-2023\/","url":"https:\/\/nanostherapeutics.com\/2023\/11\/03\/nanoscope-therapeutics-awarded-best-of-show-for-retina-at-eyeceleratoraao-2023\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u304cEyecelerator@AAO 2023\u3067\u7db2\u819c\u90e8\u9580\u306e\u300c\u30d9\u30b9\u30c8\u30fb\u30aa\u30d6\u30fb\u30b7\u30e7\u30fc\u300d\u3092\u53d7\u8cde - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2023\/11\/03\/nanoscope-therapeutics-awarded-best-of-show-for-retina-at-eyeceleratoraao-2023\/#primaryimage"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2023\/11\/03\/nanoscope-therapeutics-awarded-best-of-show-for-retina-at-eyeceleratoraao-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2023\/11\/NSCOPE_team_eyecelerator_bestofshow.jpg","datePublished":"2023-11-03T20:34:50+00:00","dateModified":"2025-06-27T16:28:56+00:00","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/nanostherapeutics.com\/2023\/11\/03\/nanoscope-therapeutics-awarded-best-of-show-for-retina-at-eyeceleratoraao-2023\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanostherapeutics.com\/2023\/11\/03\/nanoscope-therapeutics-awarded-best-of-show-for-retina-at-eyeceleratoraao-2023\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/2023\/11\/03\/nanoscope-therapeutics-awarded-best-of-show-for-retina-at-eyeceleratoraao-2023\/#primaryimage","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2023\/11\/NSCOPE_team_eyecelerator_bestofshow.jpg","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2023\/11\/NSCOPE_team_eyecelerator_bestofshow.jpg","width":1352,"height":1077},{"@type":"BreadcrumbList","@id":"https:\/\/nanostherapeutics.com\/2023\/11\/03\/nanoscope-therapeutics-awarded-best-of-show-for-retina-at-eyeceleratoraao-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanostherapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Nanoscope Therapeutics Awarded \u2018Best of Show\u2019 for Retina at Eyecelerator@AAO 2023"}]},{"@type":"WebSite","@id":"https:\/\/nanostherapeutics.com\/#website","url":"https:\/\/nanostherapeutics.com\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5e0c\u671b\u306e\u5149\u3092\u53d6\u308a\u623b\u3059","publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"alternateName":"Nanoscope Therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanostherapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/nanostherapeutics.com\/#organization","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","alternateName":"Nanoscope Therapeutics","url":"https:\/\/nanostherapeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","width":512,"height":435,"caption":"Nanoscope Therapeutics, Inc"},"image":{"@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NSTherapeutics","https:\/\/www.linkedin.com\/company\/nanoscope"]},{"@type":"Person","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9"}]}},"_links":{"self":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5467","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/comments?post=5467"}],"version-history":[{"count":2,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5467\/revisions"}],"predecessor-version":[{"id":9064,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5467\/revisions\/9064"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media\/5469"}],"wp:attachment":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media?parent=5467"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/categories?post=5467"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/tags?post=5467"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}